10% VDA-1102

DRUG2 trials

Sponsors

Vidac Pharma

Conditions

Actinic Keratosis

Phase 2

Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis

CompletedNCT02844777

Vidac PharmaActinic Keratosis

Start: 2016-07-15End: 2017-05-26Updated: 2023-01-12

Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis

CompletedNCT03538951

Vidac PharmaActinic Keratosis

Start: 2018-05-23End: 2018-12-10Updated: 2022-08-23